Screening breast cancer patients for Norwegian ATM mutations

Screening breast cancer patients for Norwegian ATM mutations

Bibliographic Details
Main Authors:	Laake, K, Vu, P, Andersen, TI, Erikstein, B, Kåresen, R, Lønning, PE, Skovlund, E, Børresen-Dale, A-L
Format:	Online
Language:	English
Published:	BioMed Central 2000
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300861/

Similar Items

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
by: Andersen, TI, et al.
Published: (2000)

Genetic variants of CYP19 (aromatase) and breast cancer risk
by: Nedelcheva Kristensen, V, et al.
Published: (2000)

ATM mutations associated with breast cancer
by: Gatti, RA, et al.
Published: (2005)

Expression of wild-type and mutated TP53 in breast carcinomas
by: Baumbusch, LO, et al.
Published: (2005)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
by: Langerød, A, et al.
Published: (2000)

Clinical trials in breast cancer; do we have the right approaches?
by: Lønning, PE
Published: (2000)

ATM variants and cancer risk in breast cancer patients from Southern Finland
by: Tommiska, Johanna, et al.
Published: (2006)

Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study
by: Lund, Eiliv, et al.
Published: (2013)

Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
by: Hofvind, Solveig, et al.
Published: (2013)

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.
by: Appleby, J. M., et al.
Published: (1997)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
by: Langerød, A, et al.
Published: (2005)

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
by: Bernstein, Jonine L, et al.
Published: (2002)

ATM gene mutations in sporadic breast cancer patients from Brazil
by: Mangone, Flavia Rotea, et al.
Published: (2015)

p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
by: Geisler, S, et al.
Published: (2000)

DHPLC Screening of ATM Gene in Italian Patients Affected by Ataxia-Telangiectasia: Fourteen Novel ATM Mutations
by: Magliozzi, Monia, et al.
Published: (2006)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
by: Yoshimura, Noriko, et al.
Published: (2004)

Mutation at Intronic Repeats of the Ataxia-Telangiectasia Mutated (ATM) Gene and ATM Protein Loss in Primary Gastric Cancer with Microsatellite Instability
by: Kim, Hee Sung, et al.
Published: (2013)

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
by: Edvardsen, Hege, et al.
Published: (2007)

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
by: Drageset, V, et al.
Published: (2005)

Rare variants in the ATM gene and risk of breast cancer
by: Goldgar, David E, et al.
Published: (2011)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
by: Langerød, Anita, et al.
Published: (2007)

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
by: Knappskog, Stian, et al.
Published: (2012)

LAN, ATM, and LAN Emulation Technologies
by: Dale, Poulter
Published: (1998)

Relation of gene expression-based tumor subclasses to clinical phenotypes
by: Sørlie, T, et al.
Published: (2000)

Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program
by: Moshina, Nataliia, et al.
Published: (2015)

Expression profiling of breast cancer, influence of tumor genotype and patient genotype
by: Borresen-Dale, A-L
Published: (2003)

Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
by: Hartmann-Johnsen, Olaf Johan, et al.
Published: (2015)

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer
by: Akslen, L A, et al.
Published: (2011)

Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
by: Olaf Johan Hartmann-Johnsen, et al.
Published: (2017-07-01)

TP53 and additional pathways in therapy resistance
by: Lønning, PE
Published: (2005)

Identification of ATM Mutations in Korean Siblings with Ataxia-Telangiectasia
by: Huh, Hee Jae, et al.
Published: (2013)

Ataxia-Telangiectasia with Novel Splicing Mutations in the ATM Gene
by: Jeong, Heejeong, et al.
Published: (2014)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
by: Van Ghelue, M, et al.
Published: (2005)

Prevalence of deleterious ATM germline mutations in gastric cancer patients
by: Huang, Dong-Sheng, et al.
Published: (2015)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
by: Broeks, Annegien, et al.
Published: (2007)

Association of Ataxia Telangiectasia Mutated (ATM) Gene Mutation/Deletion with Rhabdomyosarcoma – retraction
by: Zhang, Peilin, et al.
Published: (2003)

Association of Ataxia Telangiectasia Mutated (ATM) gene mutation/deletion with Rhabdomyosarcoma
by: Zhang, Peilin, et al.
Published: (2003)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
by: Silwal-Pandit, Laxmi, et al.
Published: (2015)

Mutations for the people
by: Kristensen, Vessela, et al.
Published: (2010)

Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study
by: Lorentzen, Jon A., et al.
Published: (2016)